Ultra Low Dose Radiation Therapy in Treating Patients With Mycosis Fungoides

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT03398161
Phase
PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Localized Skin Lesion
  • Mycosis Fungoides

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quality-of-Life Assessment — OTHER
    Ancillary studies
  • Questionnaire Administration — OTHER
    Ancillary studies
  • Radiation Therapy — RADIATION
    Undergo ultra low dose radiation therapy

Study Details

This phase II trial studies how well ultra low dose radiation therapy works in treating patients with mycosis fungoides. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Giving ultra low doses of radiation may help control the disease and reduce side effects compared to treatment with higher doses.

Key Dates

Start date
Jan 6, 2018
Status verified
Apr 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment (ultra low dose radiation therapy)
    Patients undergo ultra low dose radiation therapy at the discretion of the treating physician.

Primary Outcome Measure

Local cutaneous control [ Time Frame: At 12 (+/-2) weeks after initial treatment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
M D Anderson Cancer CenterHoustonTexas77030
Bouthaina S. Dabaja
713-563-2300
Bouthaina S. Dabaja (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site
M D Anderson Cancer Center· Houston, TX

Related Studies